$113 Million is the total value of Defender Capital, LLC.'s 19 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BRKB | Sell | BERKSHIRE HATHAWAY | $25,651,000 | +0.8% | 113,252 | -7.5% | 22.78% | +0.9% |
CFX | Sell | COLFAX CORPORATION | $6,150,000 | +19.2% | 169,043 | -4.9% | 5.46% | +19.3% |
WINA | Sell | WINMARK CORPORATION | $3,696,000 | +8.1% | 18,636 | -3.9% | 3.28% | +8.2% |
DHR | Sell | DANAHER CORPORATION | $2,129,000 | -89.4% | 138,772 | -0.8% | 1.89% | -89.4% |
INO | Sell | INOVIO PHARMA | $1,884,000 | +47.3% | 570,800 | -8.3% | 1.67% | +47.4% |
AGE | Sell | AGEX THERAPEUTICS INC | $251,000 | -38.3% | 138,192 | -32.6% | 0.22% | -38.2% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-03
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BERKSHIRE HATHAWAY INC DEL CL B | 20 | Q3 2023 | 24.4% |
DANAHER CORPORATION COM | 20 | Q3 2023 | 18.3% |
STAAR SURGICAL CORPORATION | 20 | Q3 2023 | 20.2% |
FORTIVE CORPORATION | 20 | Q3 2023 | 14.3% |
MONSTER BEVERAGE CORPORATION | 20 | Q3 2023 | 17.3% |
APPLE INC | 20 | Q3 2023 | 0.6% |
AMAZON INC COM | 20 | Q3 2023 | 0.4% |
VANGUARD SHORT TERM TREASURY ETF IV | 17 | Q3 2023 | 23.9% |
LINEAGE CELL THERAPEUTICS INC | 17 | Q3 2023 | 4.8% |
COMPUGEN LTD ORD | 17 | Q1 2023 | 1.9% |
View Defender Capital, LLC.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-06 |
13F-HR | 2024-01-23 |
13F-HR | 2023-10-23 |
13F-HR | 2023-07-18 |
13F-HR/A | 2023-05-16 |
13F-HR | 2023-04-27 |
13F-HR | 2023-01-12 |
13F-HR | 2022-10-18 |
13F-HR | 2022-07-26 |
13F-HR/A | 2022-06-07 |
View Defender Capital, LLC.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.